Skip to main content

Table 1 Demographic, anthropometric, illness severity and outcome dataa

From: Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?

Variable N = 48
Age, yr 47.3 (17.9)
Male sex, n (%) 27 (56.3)
Height, m 1.70 (0.11)
Weight, kg 88.4 (24.2)
BMI, kg/m2 30.7 (8.78)
BSA, m2 1.98 (0.26)
Admission category/system, n (%)  
  Medical n = 13
   Cardiac 1 (7.7)
   Gastrointestinal 3 (23.1)
   Neurological 2 (15.4)
   Respiratory 5 (38.5)
   Primary bacteraemia 1 (7.7)
   Oncology 1 (7.7)
  Surgical n = 13
   Gastrointestinal 7 (53.8)
   Gynaecological 1 (7.7)
   Maxillofacial 2 (15.4)
   Neurological 2 (15.4)
   Vascular 1 (7.7)
  Trauma n = 22
   Burns 6 (27.3)
   Facial 1 (4.5)
   Abdominal 4 (18.2)
   Neurological 5 (22.7)
   Orthopaedic 3 (13.6)
   Thoracic 3 (13.6)
APACHE II score 19.4 (6.79)
Modified SOFA score, median (IQR) 3.5 (2 to 6)
Mechanical ventilation, n (%) 45 (93.8)
Use of vasopressors, n (%) 12 (25.0)
Presumed/confirmed site of infection, n (%)  
  Intraabdominal 14 (29.2)
  Skin/soft tissue 5 (10.4)
  Respiratory 24 (50.0)
  Urinary 1 (2.1)
  Primary bacteraemia 1 (2.1)
  Unknown 3 (6.3)
24-hr fluid balance, ml 553 (1836)
Plasma CR, μmol/L 79.5 (31.4)
Measured CLCR, ml/min 122 (59.2)
ICU length of stay, days 18.2 (11.5)
ICU mortality, n (%) 4 (8.3)
Hospital mortality, n (%) 5 (10.4)
  1. aAPACHE, Acute Physiology and Chronic Health Evaluation; BMI, Body mass index; BSA, Body surface area; CLCR, Creatinine clearance; CR, Creatinine; ICU, Intensive care unit; IQR, Interquartile range; SD, Standard deviation; SOFA, Sequential Organ Failure Assessment. Data presented are mean (SD) unless otherwise stated.